Q3 2024 bluebird bio Inc Earnings Call
Welcome to bluebird bio's third quarter 2024 results conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer ...
Bluebird bio says it needs cash to operate beyond March 2025
Bluebird bio Inc., which nine years ago was worth nearly as much as the airline JetBlue, said it's now looking for enough ...
bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
SOMERVILLE, Mass., November 14, 2024--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported third quarter results and business highlights for the quarter ended September ...
Business Insider15h
Bluebird Bio (BLUE) Receives a Hold from William Blair
William Blair analyst Sami Corwin reiterated a Hold rating on Bluebird Bio (BLUE – Research Report) today. The company’s shares closed today at $0.36. Corwin covers the Healthcare sector, focusing on ...
bluebird bio (NASDAQ:BLUE) Coverage Initiated by Analysts at StockNews.com
Research analysts at StockNews.com assumed coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research ...
Bluebird: Q3 Earnings Snapshot
SOMERVILLE, Mass. (AP) — SOMERVILLE, Mass. (AP) — Bluebird Bio Inc. (BLUE) on Thursday reported a loss of $60.8 million in its third quarter. On a per-share basis, the Somerville, Massachusetts-based ...
Exploring bluebird bio's Earnings Expectations
Analysts estimate that bluebird bio will report an earnings per share (EPS) of $-0.37. Anticipation surrounds bluebird bio's announcement, with investors hoping to hear about both surpassing estimates ...
bovnews3d
bluebird bio Inc (BLUE) Stock: More Resilient Than It Appears
JP Morgan has recently reduced bluebird bio Inc (BLUE) stock to Neutral rating, as announced on August 15, 2024, according to Finviz. Earlier, on December 11, 2023, HSBC Securities had reduced the ...
Morningstar8d
bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today announced that it partially adjourned its annual meeting of stockholders (“Annual Meeting”) on Wednesday ...
bovnews1d
Stock Shock: The Unpredictable Rise and Fall of BLUE—What’s Driving the Drama?
On Tuesday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.39 which represents a decrease of $-0.02 or -4.88% from the prior close of $0.41. The stock opened at $0.4 and touched a ...
Business Wire8d
bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today announced that it partially adjourned its annual meeting of stockholders ...